Emily R. Nadelmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emily R. Nadelmann has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Alexander B. Pinus
Section of Hematology and Oncology, Connecticut Veterans Administration Health System, West Haven, CT, USA
1 shared publication - Alfred Ian Lee
Yale School of Medicine
1 shared publication - Amisha Patel
Yale School of Medicine
1 shared publication - Brett King
Yale School of Medicine New Haven Connecticut USA
1 shared publication - Bryan Nolasco
Albert Einstein College of Medicine, Bronx, USA
1 shared publication - C-Hong Chang
Yale School of Medicine
1 shared publication
Latest Publications
- 8 January 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (3) , 1924-1926
Multimodal Therapy in Cutaneous Angiosarcoma: A National Cancer Database Study of Treatment Patterns and Survival
- 8 January 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (3) , 1924-1926
Multimodal Therapy in Cutaneous Angiosarcoma: A National Cancer Database Study of Treatment Patterns and Survival
- Open Access
A neutrophil activation signature predicts critical illness and mortality in COVID-19
Pathologic immune hyperactivation is emerging as a key feature of critical illness in COVID-19, but the mechanisms involved remain poorly understood. We carried out proteomic profiling of plasma from cross-sectional and longitudinal cohorts of hospitalized patients with COVID-19 and analyzed clinical data from our health system database of over 3,300 patients. Using a machine learning algorithm, we identified a prominent signature of neutrophil activation, including resistin, lipocalin-2, HGF, IL-8, and G-CSF, as the strongest predictors of critical illness. Neutrophil activation was present on the first day of hospitalization in patients who would only later require transfer to the intensive care unit, thus preceding the onset of critical illness and predicting increased mortality. In the health system database, early elevations in developing and mature neutrophil counts also predicted higher mortality rates. Altogether, we define an essential role for neutrophil activation in the pathogenesis of severe COVID-19 and identify molecular neutrophil markers that distinguish patients at risk of future clinical decompensation.
Open AccessA neutrophil activation signature predicts critical illness and mortality in COVID-19
Pathologic immune hyperactivation is emerging as a key feature of critical illness in COVID-19, but the mechanisms involved remain poorly understood. We carried out proteomic profiling of plasma from cross-sectional and longitudinal cohorts of hospitalized patients with COVID-19 and analyzed clinical data from our health system database of over 3,300 patients. Using a machine learning algorithm, we identified a prominent signature of neutrophil activation, including resistin, lipocalin-2, HGF, IL-8, and G-CSF, as the strongest predictors of critical illness. Neutrophil activation was present on the first day of hospitalization in patients who would only later require transfer to the intensive care unit, thus preceding the onset of critical illness and predicting increased mortality. In the health system database, early elevations in developing and mature neutrophil counts also predicted higher mortality rates. Altogether, we define an essential role for neutrophil activation in the pathogenesis of severe COVID-19 and identify molecular neutrophil markers that distinguish patients at risk of future clinical decompensation.